Arvindselvan Mohanaselvan, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 311 W I St, Los Banos, CA 93635 Phone: 209-826-2222 Fax: 209-827-9998 |
News Archive
A newly identified gene mutation helps explain a subset of cases of osteogenesis imperfecta (OI), or brittle bone disease, whose origin had until now remained mysterious.
Global Med Technologies(R), Inc. an international healthcare information technology company, today announced that it has signed a binding letter of intent with verIDentia SL of Macanet De La Selva, Girona, Spain for its verIDhemos transfusion safety system. Terms of the agreement were not disclosed.
Women who suffer from the frustrating and painful chronic symptoms of uterine fibroids have a safe and effective alternative to surgery according to new five-year studies presented at an annual meeting of the Society of Interventional Radiology held in April. Studies found that uterine fibroid embolization has a 73 percent success rate at five years.
QLT Inc. has announced a ruling in the on-going litigation between plaintiff TAP Pharmaceutical Products, Inc. and its co-plaintiffs and defendants QLT USA, Inc. and Sanofi-Synthelabo Inc., a member of the Sanofi-aventis Group.
Researchers from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have conducted a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
› Verified 4 days ago